List of Tables
Table 1. Global Targeted Therapy Drugs for Melanoma Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Targeted Therapy Drugs for Melanoma Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Targeted Therapy Drugs for Melanoma Market Competitive Situation by Manufacturers in 2025
Table 4. Global Targeted Therapy Drugs for Melanoma Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Targeted Therapy Drugs for Melanoma Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Targeted Therapy Drugs for Melanoma Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Targeted Therapy Drugs for Melanoma Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Targeted Therapy Drugs for Melanoma, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Product Types and Applications
Table 12. Global Key Manufacturers of Targeted Therapy Drugs for Melanoma, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeted Therapy Drugs for Melanoma Companies by Tier (Tier 1, Tier 2, Tier 3), based on Targeted Therapy Drugs for Melanoma Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeted Therapy Drugs for Melanoma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Targeted Therapy Drugs for Melanoma Sales by Region (K Units), 2021–2026
Table 18. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Region (2021–2026)
Table 19. Global Targeted Therapy Drugs for Melanoma Sales by Region (K Units), 2027–2032
Table 20. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Region (2027–2032)
Table 21. Global Targeted Therapy Drugs for Melanoma Revenue by Region (US$ Million), 2021–2026
Table 22. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Region (2021–2026)
Table 23. Global Targeted Therapy Drugs for Melanoma Revenue by Region (US$ Million), 2027–2032
Table 24. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Region (2027–2032)
Table 25. North America Targeted Therapy Drugs for Melanoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Targeted Therapy Drugs for Melanoma Sales by Country (K Units), 2021–2026
Table 27. North America Targeted Therapy Drugs for Melanoma Sales by Country (K Units), 2027–2032
Table 28. North America Targeted Therapy Drugs for Melanoma Revenue by Country (US$ Million), 2021–2026
Table 29. North America Targeted Therapy Drugs for Melanoma Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Targeted Therapy Drugs for Melanoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Targeted Therapy Drugs for Melanoma Sales by Country (K Units), 2021–2026
Table 32. Europe Targeted Therapy Drugs for Melanoma Sales by Country (K Units), 2027–2032
Table 33. Europe Targeted Therapy Drugs for Melanoma Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Targeted Therapy Drugs for Melanoma Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Targeted Therapy Drugs for Melanoma Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Targeted Therapy Drugs for Melanoma Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Targeted Therapy Drugs for Melanoma Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Targeted Therapy Drugs for Melanoma Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Targeted Therapy Drugs for Melanoma Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Targeted Therapy Drugs for Melanoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Targeted Therapy Drugs for Melanoma Sales by Country (K Units), 2021–2026
Table 42. Latin America Targeted Therapy Drugs for Melanoma Sales by Country (K Units), 2027–2032
Table 43. Latin America Targeted Therapy Drugs for Melanoma Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Targeted Therapy Drugs for Melanoma Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Targeted Therapy Drugs for Melanoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Targeted Therapy Drugs for Melanoma Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Targeted Therapy Drugs for Melanoma Revenue by Country (US$ Million), 2027–2032
Table 50. Global Targeted Therapy Drugs for Melanoma Sales (K Units) by Type (2021–2026)
Table 51. Global Targeted Therapy Drugs for Melanoma Sales (K Units) by Type (2027–2032)
Table 52. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2021–2026)
Table 53. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Type (2027–2032)
Table 54. Global Targeted Therapy Drugs for Melanoma Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Targeted Therapy Drugs for Melanoma Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2021–2026)
Table 57. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Type (2027–2032)
Table 58. Global Targeted Therapy Drugs for Melanoma Price (US$/Unit) by Type (2021–2026)
Table 59. Global Targeted Therapy Drugs for Melanoma Price (US$/Unit) by Type (2027–2032)
Table 60. Global Targeted Therapy Drugs for Melanoma Sales (K Units) by Application (2021–2026)
Table 61. Global Targeted Therapy Drugs for Melanoma Sales (K Units) by Application (2027–2032)
Table 62. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2021–2026)
Table 63. Global Targeted Therapy Drugs for Melanoma Sales Market Share by Application (2027–2032)
Table 64. Global Targeted Therapy Drugs for Melanoma Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Targeted Therapy Drugs for Melanoma Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2021–2026)
Table 67. Global Targeted Therapy Drugs for Melanoma Revenue Market Share by Application (2027–2032)
Table 68. Global Targeted Therapy Drugs for Melanoma Price (US$/Unit) by Application (2021–2026)
Table 69. Global Targeted Therapy Drugs for Melanoma Price (US$/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Roche Targeted Therapy Drugs for Melanoma Product
Table 74. Roche Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Targeted Therapy Drugs for Melanoma Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis Targeted Therapy Drugs for Melanoma Product
Table 84. Novartis Recent Developments/Updates
Table 85. KeChow Pharmaceuticals Company Information
Table 86. KeChow Pharmaceuticals Description and Business Overview
Table 87. KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. KeChow Pharmaceuticals Targeted Therapy Drugs for Melanoma Product
Table 89. KeChow Pharmaceuticals Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Targeted Therapy Drugs for Melanoma Distributors List
Table 93. Targeted Therapy Drugs for Melanoma Customers List
Table 94. Targeted Therapy Drugs for Melanoma Market Trends
Table 95. Targeted Therapy Drugs for Melanoma Market Drivers
Table 96. Targeted Therapy Drugs for Melanoma Market Challenges
Table 97. Targeted Therapy Drugs for Melanoma Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeted Therapy Drugs for Melanoma
Figure 2. Global Targeted Therapy Drugs for Melanoma Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Targeted Therapy Drugs for Melanoma Market Share by Type: 2025 & 2032
Figure 4. MEK Inhibitors Product Picture
Figure 5. BRAF Inhibitors Product Picture
Figure 6. Other Product Picture
Figure 7. Global Targeted Therapy Drugs for Melanoma Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Targeted Therapy Drugs for Melanoma Market Share by Application: 2025 & 2032
Figure 9. Hospital and Clinic
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Global Targeted Therapy Drugs for Melanoma Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Targeted Therapy Drugs for Melanoma Market Size (US$ Million), 2021–2032
Figure 14. Global Targeted Therapy Drugs for Melanoma Sales (K Units), 2021–2032
Figure 15. Global Targeted Therapy Drugs for Melanoma Average Price (US$/Unit), 2021–2032
Figure 16. Targeted Therapy Drugs for Melanoma Report Years Considered
Figure 17. Targeted Therapy Drugs for Melanoma Sales Share by Manufacturers in 2025
Figure 18. Global Targeted Therapy Drugs for Melanoma Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Targeted Therapy Drugs for Melanoma Players: Market Share by Revenue in Targeted Therapy Drugs for Melanoma in 2025
Figure 20. Targeted Therapy Drugs for Melanoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Targeted Therapy Drugs for Melanoma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021–2032)
Figure 23. North America Targeted Therapy Drugs for Melanoma Revenue Market Share by Country (2021–2032)
Figure 24. United States Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021–2032)
Figure 27. Europe Targeted Therapy Drugs for Melanoma Revenue Market Share by Country (2021–2032)
Figure 28. Germany Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Targeted Therapy Drugs for Melanoma Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Targeted Therapy Drugs for Melanoma Revenue Market Share by Region (2021–2032)
Figure 35. China Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021–2032)
Figure 43. Latin America Targeted Therapy Drugs for Melanoma Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Targeted Therapy Drugs for Melanoma Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Targeted Therapy Drugs for Melanoma Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Targeted Therapy Drugs for Melanoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Targeted Therapy Drugs for Melanoma by Type (2021–2032)
Figure 54. Global Revenue Market Share of Targeted Therapy Drugs for Melanoma by Type (2021–2032)
Figure 55. Global Targeted Therapy Drugs for Melanoma Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Targeted Therapy Drugs for Melanoma by Application (2021–2032)
Figure 57. Global Revenue Market Share of Targeted Therapy Drugs for Melanoma by Application (2021–2032)
Figure 58. Global Targeted Therapy Drugs for Melanoma Price (US$/Unit) by Application (2021–2032)
Figure 59. Targeted Therapy Drugs for Melanoma Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
